NCT00144794

Brief Summary

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients receiving enzyme replacement therapy, such as Aldurazyme (Recombinant Human Alpha-L-Iduronidase), or other treatment modalities. The objectives of the Registry are:

  • To evaluate the long-term effectiveness and safety of Aldurazyme® (laronidase)
  • To characterize and describe the MPS I population as a whole, including the variability, progression, and natural history of MPS I
  • To help the MPS I medical community with the development of recommendations for monitoring patients and reports on patient outcomes to optimize patient care

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
1,406

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2003

Longer than P75 for all trials

Geographic Reach
37 countries

141 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2003

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2005

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 5, 2005

Completed
19.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

21.1 years

First QC Date

September 2, 2005

Last Update Submit

February 24, 2026

Conditions

Keywords

Hurler's SyndromeHurler-Scheie SyndromeScheie Syndrome

Outcome Measures

Primary Outcomes (1)

  • To evaluate the long-term effectiveness of Aldurazyme

    Approximately 17 Years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All Patients with MPS I

You may qualify if:

  • For all patients there should be a completed patient authorization form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (141)

Phoenix Children's Hospital- Site Number : 840003

Phoenix, Arizona, 85016, United States

Location

Arkansas Children's Hospital- Site Number : 840109

Little Rock, Arkansas, 72202, United States

Location

Southern California Permanente Medical Group- Site Number : 840108

Los Angeles, California, 90027, United States

Location

USC Health Sciences Center Dept of Genetics- Site Number : 840082

Los Angeles, California, 90033, United States

Location

UCSF Benioff Children's Hospital - Oakland- Site Number : 840029

Oakland, California, 94609, United States

Location

Children's Hospital of Orange County- Site Number : 840074

Orange, California, 92868, United States

Location

Stanford Unviersity MC Dept of Genetics- Site Number : 840022

Palo Alto, California, 94305, United States

Location

UC Davis MIND Institute- Site Number : 840010

Sacramento, California, 95817, United States

Location

University of California at San Diego- Site Number : 840007

San Diego, California, 92093, United States

Location

University of California at San Francisco- Site Number : 840051

San Francisco, California, United States

Location

Children's Hospital Colorado - Aurora- Site Number : 840069

Aurora, Colorado, 80045, United States

Location

University of Colorado at Denver Genetics Site Number : 840068

Aurora, Colorado, 80045, United States

Location

Yale University School of Medicine- Site Number : 840047

New Haven, Connecticut, 06510, United States

Location

Children's National Medical Center - Washington- Site Number : 840067

Washington D.C., District of Columbia, 20010, United States

Location

University of Florida Dept of Genetics- Site Number : 840083

Gainesville, Florida, 32610, United States

Location

University Of Miami SOM- Site Number : 840006

Miami, Florida, 33136, United States

Location

Pediatric Endocrine Associates- Site Number : 840017

Tampa, Florida, 33612, United States

Location

Emory University School of Medicine- Human Genetics- Site Number : 840060

Decatur, Georgia, 30033, United States

Location

Ann & Robert H. Lurie Children's Hospital of Chicago- Site Number : 840011

Chicago, Illinois, 60611, United States

Location

Rush University Medical Center Genetics- Site Number : 840079

Chicago, Illinois, 60612, United States

Location

Indianapolis University School of Medicine- Site Number : 840027

Indianapolis, Indiana, 46202, United States

Location

University of Iowa- Site Number : 840032

Iowa City, Iowa, 52242, United States

Location

University of Louisville- Genetics- Site Number : 840030

Louisville, Kentucky, 40202, United States

Location

John Hopkins- Site Number : 840044

Baltimore, Maryland, United States

Location

Massachusetts General Hospital-Genetics- Site Number : 840062

Boston, Massachusetts, 02114, United States

Location

Boston Children's Hospital - PIN- Site Number : 840093

Boston, Massachusetts, 2115, United States

Location

Baystate Medical Center- Site Number : 840002

Springfield, Massachusetts, 01199, United States

Location

University of Michigan Pediatrics- Site Number : 840107

Ann Arbor, Michigan, 48109, United States

Location

University of Minnesota Medical Center Pediatrics- Site Number : 840076

Minneapolis, Minnesota, 55455, United States

Location

Washington University- Site Number : 840100

St Louis, Missouri, 63110, United States

Location

University of Nebraska Medical Center- Site Number : 840084

Omaha, Nebraska, 68198, United States

Location

Children's Specialty Center - Las Vegas- Site Number : 840008

Las Vegas, Nevada, 89109, United States

Location

Joseph M. Sanzari Children's Hospital- Site Number : 840101

Hackensack, New Jersey, 07601, United States

Location

Saint Peter's University Hospital - New Brunswick- Site Number : 840016

New Brunswick, New Jersey, 08901, United States

Location

Northwell Health - Site Number : 840102

Manhasset, New York, 11030, United States

Location

New York University School Of Medicine- Site Number : 840040

New York, New York, 10016, United States

Location

State University of New York- Site Number : 840052

Syracuse, New York, 13210, United States

Location

Duke University Medical Center Genetics Dept- Site Number : 840037

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Hospital-Genetics- Site Number : 840041

Cincinnati, Ohio, United States

Location

Nationwide Children's Hospital- Site Number : 840091

Columbus, Ohio, 43205, United States

Location

Oregon Health & Science University (OHSU)- Site Number : 840080

Portland, Oregon, 97239, United States

Location

Children's Hospital of Philadelphia HUP Medical Genetics- Site Number : 840089

Philadelphia, Pennsylvania, 19104, United States

Location

Children's Hospital of Philadelphia- Site Number : 840034

Philadelphia, Pennsylvania, United States

Location

University of Pittsburgh- Site Number : 840023

Pittsburgh, Pennsylvania, 15224, United States

Location

Rhode Island Hospital Genetics- Site Number : 840053

Providence, Rhode Island, 02903, United States

Location

Greenwood Genetic Center - Greenville- Site Number : 840055

Greenville, South Carolina, 29605, United States

Location

Baylor Institute of Metabolic Disease- Site Number : 840058

Dallas, Texas, 75226, United States

Location

University of Utah Health Hospital- Site Number : 840092

Salt Lake City, Utah, 84132, United States

Location

University of Virginia School of Medicine-Pediatrics- Site Number : 840078

Charlottesville, Virginia, 22908, United States

Location

Children's Hospital of The King's Daughters- Site Number : 840072

Norfolk, Virginia, 23507, United States

Location

Seattle Children's Hospital- Site Number : 840028

Seattle, Washington, 98105, United States

Location

University Of Washington Medical Center- Site Number : 840059

Seattle, Washington, 98195, United States

Location

Children's Hospital of Wisconsin-Pediatrics- Site Number : 840054

Milwaukee, Wisconsin, 53226, United States

Location

Investigational Site Number : 153032

Buenos Aires, 1192, Argentina

Location

Investigational Site Number : 153130

San Luis, 5700, Argentina

Location

Investigational Site Number : 151069

Westmead, New South Wales, 2145, Australia

Location

Investigational Site Number : 150944

Brussels, 1090, Belgium

Location

Investigational Site Number : 151668

Leuven, 3000, Belgium

Location

Investigational Site Number : 154008

Roeselare, 8800, Belgium

Location

Private Practice - Dr. Fabiano Klaus- Site Number : 076001

Porto Alegre, Rio Grande do Sul, 90035-002, Brazil

Location

Hospital e Maternidade Celso Pierro - PUC-Campinas- Site Number : 076007

Campinas, São Paulo, 13034-685, Brazil

Location

Instituto Fernandes Figueira - FIOCRUZ- Site Number : 076004

Rio de Janeiro, 22250-020, Brazil

Location

Instituto de Genética e Erros Inatos do Metabolismo- Site Number : 076002

São Paulo, 04020-041, Brazil

Location

Investigational Site Number : 124014

Calgary, Alberta, T2E 7Z4, Canada

Location

Investigational Site Number : 124002

Edmonton, Alberta, T6G 2B7, Canada

Location

Investigational Site Number : 124011

Vancouver, British Columbia, V6H 3N1, Canada

Location

Investigational Site Number : 124019

Winnipeg, Manitoba, R3A 1R9, Canada

Location

Investigational Site Number : 124021

London, Ontario, N6A 5A5, Canada

Location

Investigational Site Number : 124018

Ottawa, Ontario, K1K 4L2, Canada

Location

Investigational Site Number : 124006

Toronto, Ontario, M5G 1X8, Canada

Location

Investigational Site Number : 124001

Sherbrooke, Quebec, J1K 2R1, Canada

Location

Investigational Site Number : 152001

Talcahuano, Región del Biobío, 2687000, Chile

Location

Investigational Site Number : 152003

Los Ángeles, Chile

Location

Investigational Site Number : 170001

Bogotá, Colombia

Location

Investigational Site Number : 150659

Prague, 12808, Czechia

Location

Investigational Site Number : 151229

Copenhagen, 2100, Denmark

Location

Investigational Site Number : 818002

Cairo, 11231, Egypt

Location

Investigational Site Number : 818001

Cairo, Egypt

Location

Investigational Site Number : 250004

Bordeaux, 33076, France

Location

Investigational Site Number : 250001

Bron, 69677, France

Location

Investigational Site Number : 250002

Marseille, 13885, France

Location

Investigational Site Number : 250003

Paris, 75015, France

Location

Investigational Site Number : 250006

Vandœuvre-lès-Nancy, 54511, France

Location

Investigational Site Number : 151368

Hamburg, 20246, Germany

Location

Investigational Site Number : 150031

Mainz, 55131, Germany

Location

Investigational Site Number : 344001

Kowloon, Hong Kong

Location

Investigational Site Number : 356003

Ahmedabad, 380015, India

Location

Investigational Site Number : 356001

Kolkata, 700017, India

Location

Investigational Site Number : 356002

Vellore, 632004, India

Location

Investigational Site Number : 360001

Jakarta, Indonesia

Location

Investigational Site Number : 154161

Dublin, D01 F772, Ireland

Location

Investigational Site Number : 380004

Cusano Milanino, Milano, 20095, Italy

Location

Investigational Site Number : 380007

Milan, Milano, 20142, Italy

Location

Investigational Site Number : 380006

Rome, Roma, 00165, Italy

Location

Investigational Site Number : 380002

Ancona, 60126, Italy

Location

Investigational Site Number : 380003

Genova, 16147, Italy

Location

Investigational Site Number : 380005

Naples, Italy

Location

Investigational Site Number : 380008

Padua, 35128, Italy

Location

Investigational Site Number : 392102

Nankoku, Kochi, 783-8505, Japan

Location

Investigational Site Number : 392101

Tokyo, 157-8535, Japan

Location

Investigational Site Number : 154225

Kuwait City, Kuwait

Location

Investigational Site Number : 4220004

Beirut, 11072210, Lebanon

Location

Investigational Site Number : 458001

Kuala Lumpur, 50586, Malaysia

Location

Investigational Site Number : 458002

Kuala Lumpur, 59100, Malaysia

Location

Investigational Site Number : 151171

Amsterdam, Netherlands

Location

Investigational Site Number : 152029

Rotterdam, 3015 CE, Netherlands

Location

Investigational Site Number : 154264

Lahore, Pakistan

Location

Investigational Site Number : 154266

Lahore, Pakistan

Location

Investigational Site Number : 608001

Manila, 1000, Philippines

Location

Investigational Site Number : 150575

Warsaw, 04-730, Poland

Location

Investigational Site Number : 6200002

Coimbra, 3000-075, Portugal

Location

Investigational Site Number : 154177

Cluj-Napoca, 400006, Romania

Location

Investigational Site Number : 643001

Moscow, 119571, Russia

Location

Investigational Site Number : 643002

Moscow, 125412, Russia

Location

Investigational Site Number : 682001

Al Qaţīf, Saudi Arabia

Location

Investigational Site Number : 682004

Mecca, 24246, Saudi Arabia

Location

Investigational Site Number : 703001

Bratislava, 833 40, Slovakia

Location

Investigational Site Number : 153191

Daejeon, South Korea

Location

Investigational Site Number : 153225

Jeonnam, South Korea

Location

Investigational Site Number : 153212

Seoul, South Korea

Location

Investigational Site Number : 153222

Seoul, South Korea

Location

Investigational Site Number : 7520001

Stockholm, 171 76, Sweden

Location

Investigational Site Number : 154093

Chiayi City, Taiwan

Location

Investigational Site Number : 152246

Kaohsiung City, 833, Taiwan

Location

Investigational Site Number : 151500

Putz City, Chia-yi, Taiwan

Location

Investigational Site Number : 151179

Taichung, 404, Taiwan

Location

Investigational Site Number : 152153

Tainan, 710, Taiwan

Location

Investigational Site Number : 151182

Taipei, 100, Taiwan

Location

Investigational Site Number : 152321

Taipei, 104, Taiwan

Location

Investigational Site Number : 764002

Bangkok, 10400, Thailand

Location

Investigational Site Number : 764003

Bangkok, 10400, Thailand

Location

Investigational Site Number : 764004

Bangkok, 10700, Thailand

Location

Investigational Site Number : 764001

Bangkok, Thailand

Location

Investigational Site Number : 154240

Birmingham, England, B4 6NH, United Kingdom

Location

Investigational Site Number : 151123

London, England, NW3 2QG, United Kingdom

Location

Investigational Site Number : 152156

Glasgow, Glasgow City, G51 4TF, United Kingdom

Location

Investigational Site Number : 151646

London, London, City of, WC1N 3BG, United Kingdom

Location

Investigational Site Number : 150303

London, London, City of, WC1N 3JH, United Kingdom

Location

Investigational Site Number : 152361

Salford, Manchester, M6 8HD, United Kingdom

Location

Investigational Site Number : 150455

Manchester, Missouri, M13 9WL, United Kingdom

Location

Investigational Site Number : 154212

Hanoi, Vietnam

Location

Related Publications (3)

  • Viskochil D, Muenzer J, Guffon N, Garin C, Munoz-Rojas MV, Moy KA, Hutchinson DT. Carpal tunnel syndrome in mucopolysaccharidosis I: a registry-based cohort study. Dev Med Child Neurol. 2017 Dec;59(12):1269-1275. doi: 10.1111/dmcn.13545. Epub 2017 Sep 11.

    PMID: 28892147BACKGROUND
  • Arn P, Bruce IA, Wraith JE, Travers H, Fallet S. Airway-related symptoms and surgeries in patients with mucopolysaccharidosis I. Ann Otol Rhinol Laryngol. 2015 Mar;124(3):198-205. doi: 10.1177/0003489414550154. Epub 2014 Sep 11.

    PMID: 25214650BACKGROUND
  • Beck M, Arn P, Giugliani R, Muenzer J, Okuyama T, Taylor J, Fallet S. The natural history of MPS I: global perspectives from the MPS I Registry. Genet Med. 2014 Oct;16(10):759-65. doi: 10.1038/gim.2014.25. Epub 2014 Mar 27.

    PMID: 24675674BACKGROUND

MeSH Terms

Conditions

Mucopolysaccharidosis I

Condition Hierarchy (Ancestors)

MucopolysaccharidosesCarbohydrate Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesLysosomal Storage DiseasesMucinosesConnective Tissue DiseasesSkin and Connective Tissue DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Medical Monitor

    Genzyme, a Sanofi Company

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2005

First Posted

September 5, 2005

Study Start

November 20, 2003

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations